THYROID CANCER

Drug GENZYME CORPORATION
Total Payments
$22,928
Transactions
17
Doctors
14
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2018 $2,500 1 0
2017 $20,428 16 14

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $19,830 3 86.5%
Grant $2,500 1 10.9%
Food and Beverage $597.64 13 2.6%

Top Doctors Receiving Payments for THYROID CANCER

Doctor Specialty Location Total Records
, MD Endocrinology, Diabetes & Metabolism Sarasota, FL $6,610 1
, MD Endocrinology, Diabetes & Metabolism New York, NY $6,610 1
, MD Endocrinology, Diabetes & Metabolism Scarborough, ME $6,610 1
Unknown Boston, MA $2,500 1
, M.D Endocrinology, Diabetes & Metabolism Newport Beach, CA $148.37 2
, MD Endocrinology, Diabetes & Metabolism Provo, UT $116.89 2
, M.D Otolaryngology Augusta, GA $96.79 1
, MD Endocrinology, Diabetes & Metabolism La Crosse, WI $55.12 1
, M.D Specialist Miami Shores, FL $39.27 1
, DO Endocrinology, Diabetes & Metabolism Fall River, MA $30.43 1
, M.D Surgery Boston, MA $25.00 1
, MD Endocrinology, Diabetes & Metabolism Fairfax, VA $22.67 1
, MD Endocrinology, Diabetes & Metabolism Reno, NV $22.45 1
, MD Nuclear Medicine Washington, DC $22.13 1
, M.D Endocrinology, Diabetes & Metabolism Clearwater, FL $18.52 1

About THYROID CANCER

THYROID CANCER is a drug associated with $22,928 in payments to 14 healthcare providers, recorded across 17 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.

Payment data is available from 2017 to 2018. In 2018, $2,500 was paid across 1 transactions to 0 doctors.

The most common payment nature for THYROID CANCER is "Consulting Fee" ($19,830, 86.5% of total).